Rob Forbes Team Janssen Oncology

Rob is the Director, Global Indication Lead at Janssen Oncology. Rob, an incredible athlete, became a strong cyclist in 2017 when he joined the inaugural R2V team on the 8-day “Desert Ride” from LA toFlagstaff, AX. In 2018, he re-upped his commitment rode on the Red Rocks team through Utah in 2018. He is back for 2019! Rob saysRoad to Victories empowers the patients who ride in the event to make a difference and allows those of us who get to know them to work even harder to find a cure.”

Proud to be along for the ride….even if there are hills.
Rob Forbes
I love the fact that I work for a company that believes in the patients that it develops drugs to treat. We invest in development, but we also invest in…
Read More
The mission of the Multiple Myeloma Research Foundation (MMRF) is to find a cure for multiple myeloma by relentlessly pursuing innovation that accelerates the development of next-generation treatments to extend the lives of patients. Founded in 1998 by Kathy Giusti, a multiple myeloma patient, and her twin sister Karen Andrews as a 501(c) (3) nonprofit organization, the MMRF is a world-recognized leader in cancer research. Together with its partners, the MMRF has created the only end-to-end solution in precision medicine and the single largest genomic dataset in all cancers. The MMRF continues to disrupt the industry today, as a pioneer and leader at the helm of new research efforts. Since its inception, the organization has raised over $400 million and directs nearly 90% of the total funds to research and related programs. Learn more and sign up to receive news and resources from the MMRF.

Learn More

At Janssen Oncology, we’re shaping the future of cancer treatment. In the process, we’re striving to change expectations of what a cancer diagnosis means. Our purpose is driven by an urgency and commitment to bringing transformational cancer solutions to the people who need them. Passionate about our work, we are driven by the personal connection many of us share with the disease. With our partners, we focus on delivering solutions that make a positive impact on human health. We are part of Janssen Biotech, Inc., and the Janssen Pharmaceutical Companies of Johnson & Johnson.

About Janssen Oncology

Click below to learn more about a treatment option for multiple myeloma. If you’re also interested in getting more information from Janssen, sign up for ongoing communications.

Learn More